Bullish Moving Averages
0
Bearish Moving Averages
16
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
20.20Today’s High
23.4052W low
19.1052W High
39.20Open Price
22.30Prev. Close
22.1900Volume
18211.00Value
414482.36Fundamentals
Market Cap
13.80
Price to Earnings
-651.00
Price to Book Value
0.90
Dividend Yield
0.00
PE to Growth
-9.00
Op Revenue TTM
2.93
Net Profit TTM
-0.02
Cash From Operating Activity
0.00
Return on Equity %
-0.14
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
67.6
Week
85.3
Month
85.4
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
22.13
PIVOT
First Resistance
24.00
Second Resistance
25.25
Third Resistance
27.12
First Support
20.88
Second Support
19.01
Third Support
17.76
Relative Strength Index
45.35
Money Flow Index
42.27
MACD
0.06
MACD Signal
0.18
Average True Range
1.78
Average Directional Index
15.21
Rate of Change (21)
4.88
Rate of Change (125)
-22.27
Commodity Channel Index
-60.2
Williams %R
-58.2
BETA
1 Month
0.22
3 Month
0.75
1 Year
0.69
3 Year
0.52
PRICE CHANGE ANALYSIS
↓ -5.72%
1 Week
Low
High
20.25
24.99
↑ 2.57%
1 Month
Low
High
19.75
26.26
↓ -12.36%
3 Months
Low
High
19.06
27
↓ -37.35%
6 Months
Low
High
19.06
39.2
↓ -8.92%
1 Year
Low
High
19.06
39.2
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 0.24 | 2.75 | 0.04 | 0.02 | 1.27 | 0.00 | 0.00 | 0.00 | 8.44 | 0.00 | 0.00 | |
| Operating Expenses Qtr | 0.31 | 2.55 | 0.10 | 0.10 | 1.25 | 0.02 | 0.02 | 0.08 | 8.72 | 0.06 | 0.10 | |
| Operating Profit Qtr | -0.17 | 0.19 | -0.06 | -0.10 | 0.02 | -0.02 | -0.02 | -0.08 | -0.28 | -0.06 | -0.10 | |
| EBIDT Qtr Cr | -0.07 | 0.20 | -0.05 | -0.08 | 0.03 | -0.02 | -0.02 | -0.08 | -0.28 | -0.06 | -0.10 | |
| Depreciation Qtr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Qtr | -0.07 | 0.19 | -0.05 | -0.09 | 0.05 | -0.03 | -0.02 | -0.08 | -0.15 | -0.07 | -0.10 | |
| Basic EPS Qtr | -0.11 | 0.31 | -0.09 | -0.15 | 0.01 | -0.01 | -0.04 | -0.01 | -0.02 | -0.01 | -0.02 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 3.05 | 1.27 | 8.44 | 16.76 | 26.89 | |
| Operating Expenses Annual Cr | 3.06 | 1.37 | 8.93 | 16.93 | 26.94 | |
| Operating Profit Annual | -0.14 | -0.10 | -0.49 | -0.16 | -0.05 | |
| Operating Profit Margin Annual % | -4.52 | -7.63 | -5.80 | -0.97 | -0.19 | |
| Total Expenses Annual Cr | 3.08 | 1.37 | 8.94 | 16.94 | 26.96 | |
| EBIDT Annual Cr | -0.02 | -0.10 | -0.49 | -0.16 | -0.05 | |
| EBIDT Annual margin % | -0.51 | -7.50 | -5.80 | -0.97 | -0.19 | |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| PAT Before ExtraOrdinary Items Annual Cr | -0.02 | -0.08 | -0.37 | -0.13 | -0.05 | |
| Net Profit Annual | -0.02 | -0.08 | -0.37 | -0.13 | -0.05 | |
| Basic EPS Annual | -0.04 | -0.13 | -0.61 | -0.21 | -0.08 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 15.14 | 15.16 | 12.55 | 12.93 | 13.06 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Liabilities Annual Cr | 0.07 | 0.23 | 0.02 | 8.62 | 8.53 | |
| Total Capital Plus Liabilities Annual Cr | 15.24 | 15.39 | 12.57 | 21.54 | 21.58 | |
| Fixed Assets Annual | 0.03 | 0.04 | 0.05 | 0.06 | 0.07 | |
| Total Non Current Assets Annual | 0.25 | 0.25 | 0.23 | 2.05 | 2.02 | |
| Total Current Assets Annual | 14.99 | 15.14 | 12.34 | 19.49 | 19.56 | |
| Total Assets Annual | 15.24 | 15.39 | 12.57 | 21.54 | 21.58 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -0.01 | 2.95 | -2.38 | -0.05 | -4.36 | |
| Cash from Investing Activity Annual | 0.00 | -2.91 | 2.35 | 0.02 | 4.36 | |
| Cash from Financing Annual Activity | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | |
| Net Cash Flow Annual | - | 0.04 | -0.03 | -0.03 | -0.01 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 24.97 | 25.00 | 20.70 | 21.32 | 21.53 | |
| ROE Annual % | -0.14 | -0.50 | -2.94 | -1.00 | -0.38 | |
| ROCE Annual % | -0.13 | -0.67 | -3.97 | -1.35 | -0.51 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | -0.53 | -7.50 | -5.80 | -0.96 | -0.18 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Mar 2019 | Mar 2018 | Mar 2017 | Graph |
|---|---|---|---|---|
| Total Revenue Annual | 54.72 | 22.84 | 5.35 | |
| Operating Expenses Annual Cr | 54.33 | 22.04 | 5.22 | |
| Operating Profit Annual | 0.10 | 0.76 | 0.06 | |
| Operating Profit Margin Annual % | 0.18 | 3.33 | 1.09 | |
| Total Expenses Annual Cr | 54.82 | 22.78 | 5.56 | |
| EBIDT Annual Cr | 0.39 | 0.80 | 0.13 | |
| EBIDT Annual margin % | 0.72 | 3.52 | 2.46 | |
| Depreciation | 0.38 | 0.45 | 0.21 | |
| PAT Before ExtraOrdinary Items Annual Cr | 0.04 | -0.00 | -0.22 | |
| Net Profit Annual | 0.04 | -0.00 | -0.22 | |
| Basic EPS Annual | 0.07 | -0.01 | -0.36 |
| Indicator | Mar 2019 | Mar 2018 | Mar 2017 | Graph |
|---|---|---|---|---|
| Total ShareHolders Funds Annual | 12.91 | 12.87 | 12.88 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 0.03 | 0.10 | 2.99 | |
| Total Current Liabilities Annual Cr | 8.27 | 2.83 | 1.40 | |
| Total Capital Plus Liabilities Annual Cr | 21.20 | 15.80 | 17.26 | |
| Fixed Assets Annual | 10.27 | 11.91 | 9.91 | |
| Total Non Current Assets Annual | 10.37 | 11.97 | 9.96 | |
| Total Current Assets Annual | 10.84 | 3.83 | 7.30 | |
| Total Assets Annual | 21.20 | 15.80 | 17.26 | |
| Contingent Liabilities plus Commitments Annual Cr | 0.00 | 4.54 | 4.54 |
| Indicator | Mar 2019 | Mar 2018 | Mar 2017 | Graph |
|---|---|---|---|---|
| Cash from Operating Activity Annual | -0.44 | 3.55 | 0.00 | |
| Cash from Investing Activity Annual | 0.00 | -2.53 | 0.00 | |
| Cash from Financing Annual Activity | -0.50 | -1.61 | 0.00 | |
| Net Cash Flow Annual | -0.94 | -0.59 | 0.00 |
| Indicator | Mar 2019 | Mar 2018 | Mar 2017 | Graph |
|---|---|---|---|---|
| Book Value Per Share Annual | 21.29 | 21.23 | 21.23 | |
| ROE Annual % | 0.31 | -0.03 | -1.69 | |
| ROCE Annual % | 0.08 | 2.74 | -0.47 | |
| Total Debt to Total Equity Annual | 0.18 | 0.17 | 0.25 | |
| EBDIT Annual Margin % | 0.72 | 3.52 | 2.49 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| RAMIT WALIA | 2.39 | 75282404 | 0 | 0 |
| SYMBIOSIS PHARMACEUTICAL PRIVATE LIMITED | 13.99 | 75282406 | 0 | 0 |
| GALAXY VITACARE PRIVATE LIMITED | 8.62 | 75282407 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| ANILKUMAR . | 4.77 | 75282417 |
| ANIL KUMAR | 2.2 | 75282418 |
| P MUKESH KUMAR | 1.86 | 75282419 |
| MIRAL HEMANTBHAI BHOOT | 1.63 | 75282420 |
| VINITA JAIN | 1.59 | 75282421 |
| SHRESTH HANUMAN KANODIA | 1.31 | 75282422 |
| UPASANA RISHI PAREKH | 1.17 | 75282423 |
| PRAKASH CHAND CHAGANLAL | 1.15 | 75282424 |
| ANSHUL JAJOO | 1.04 | 75282425 |
| HUF | 2.9 | 75282410 |
| Clearing Members | 1.38 | 75282411 |
| RAINBOW SECURITIES PRIVATE LIMITED | 1.14 | 75282412 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 29, 2024 | Audited Results | - |
| Feb 13, 2024 | Quarterly Results | - |
| Nov 08, 2023 | Quarterly Results | - |
| Aug 14, 2023 | Quarterly Results | - |
| May 30, 2023 | Audited Results | - |
| Feb 13, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Quarterly Results | - |
| Aug 13, 2022 | Quarterly Results | - |
| May 25, 2022 | Audited Results & Others | Inter alia, To consider and approve the appointment of M/s. M R Chechi & Associates, Company Secretaries, Chandigarh as Secretarial Auditors of the company for F.Y. 2022-23. |
| Feb 01, 2022 | Quarterly Results | - |
| Nov 13, 2021 | Quarterly Results | - |
| Aug 20, 2021 | Others | - |
| Jul 19, 2021 | Quarterly Results | - |
| Apr 27, 2021 | Audited Results | - |
| Feb 12, 2021 | Quarterly Results | - |
| Nov 10, 2020 | Quarterly Results | - |
| Aug 13, 2020 | Quarterly Results | - |
| Jun 29, 2020 | Audited Results | - |
| Jan 30, 2020 | Quarterly Results | - |
| Jan 27, 2020 | Others | inter alia, 1.To disinvest and transfer the shares of Healthy Biosciences Pvt Limited, pursuant to the resolution passed at the Annual General Meeting of the Company held on 30th September, 2019. |
| Dec 30, 2019 | Others | inter alia, to consider and approve the resignation of Ms. Swati Pandey, Company Secretary and Compliance Officer of the Company w.ef 31st December, 2019 |
| Oct 14, 2019 | Quarterly Results | - |
| Aug 30, 2019 | Others | Inter alia, to consider and approve 1. To Approve the Notice and Directors Report for the Annual General Meeting for the financial year ending 31st March, 2019. |
| Aug 13, 2019 | Quarterly Results | - |
| Jun 17, 2019 | Others | inter alia, 1.To consider and approve the resignation of Mr. Jasjot Singh (DIN: 09137631), Director of the Company with immediate effect. |
| May 30, 2019 | Audited Results | - |
| May 29, 2019 | Audited Results | - |
| Apr 25, 2019 | Others | inter alia, to consider and approve The appointment of M/s. Gurdeep Singh & Associates, Chartered Accountants (FRN 013916N) as Internal Auditor of the Company for the financial year 2019-20. |
| Mar 30, 2019 | Others | inter alia, to consider and approve 1.To Consider and approve the appointment of M/s. M R Chechi & Associates as a Secretarial Auditor of the Company for the financial year 2018-19. |
| Feb 14, 2019 | Quarterly Results | - |
| Dec 11, 2018 | Others | inter alia,to consider and approve To consider the appointment of Mrs. Swati Pandey as Company Secretary and Compliance Officer of the Company. |
| Nov 14, 2018 | Quarterly Results | - |
| Oct 18, 2018 | Issue Of Warrants | - |
| Aug 14, 2018 | Quarterly Results & A.G.M. | - |
| Jul 02, 2018 | Others | 1. To consider change in date of Annual General Meeting to be held. 2. To consider and approve the resignation of Ms. Shipra Anand (Company Secretary and Compliance Officer) of the Company. |
| May 30, 2018 | Audited Results | - |
| Apr 27, 2018 | Others | To consider and take on record the intimation received form Punjab Biotechnology Park Limited (Promoter) informing us the details of the release of their shares held in the company. |
| Feb 14, 2018 | Quarterly Results & Others | - |
| Dec 04, 2017 | Quarterly Results | - |
| Aug 22, 2017 | Others | - |
| Aug 12, 2017 | Quarterly Results | - |
| Jun 12, 2017 | Others | 1. To Consider Change in date of AGM to be held. 2. To Cosider and Approve the resignation of Mrs. Uma Pareekh as independent Director of the Company. |
| May 30, 2017 | Audited Results | - |
| Apr 01, 2017 | Others | - |
| Feb 14, 2017 | Quarterly Results | - |
| Jan 03, 2017 | Preferential Issue of shares | - |
| Dec 22, 2016 | Others | To Consider, Approve and take on records the appointment of Ms. Barkha Jain as a Company Secretary of the Company. |
| Nov 12, 2016 | Quarterly Results | - |
| Oct 07, 2016 | Preferential Issue of shares | - |
| Aug 13, 2016 | Quarterly Results | - |
| May 27, 2016 | Audited Results | - |
| Feb 13, 2016 | Quarterly Results | - |
| Nov 07, 2015 | Quarterly Results | - |
| Sep 02, 2015 | Appointment of Woman Director | - |
| Aug 14, 2015 | Quarterly Results | - |
| May 29, 2015 | Audited Results | - |
| Jan 30, 2015 | Quarterly Results | - |
| Nov 14, 2014 | Quarterly Results | - |
| Aug 12, 2014 | Quarterly Results | - |
| May 29, 2014 | Audited Results | - |
| Feb 12, 2014 | Quarterly Results | - |
| Nov 08, 2013 | Quarterly Results | - |
| Aug 12, 2013 | Quarterly Results | - |
| May 23, 2013 | Audited Results | - |
| Feb 11, 2013 | Quarterly Results | - |
| Oct 23, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| May 28, 2012 | Audited Results | - |
| Feb 10, 2012 | Quarterly Results | - |
| Nov 09, 2011 | Quarterly Results | - |
| Nov 03, 2011 | Raising of long term funds | Inter alia, to consider raising of long term funds through various modes. |
| Aug 12, 2011 | Quarterly Results | - |
| May 30, 2011 | Audited Results | - |
| Feb 04, 2011 | Quarterly Results | - |
| Oct 23, 2010 | Quarterly Results | - |
| Aug 09, 2010 | Quarterly Results | - |
| Jun 30, 2010 | Audited Results | - |
| Apr 30, 2010 | Quarterly Results | - |
| Jan 29, 2010 | Quarterly Results | - |
| Oct 30, 2009 | Quarterly Results & Others | The Board of Directors has approved the change in corporate office from "25, Mangaldas Road, Mumbai 400 002" to "E-18, 6th Floor, Everest Bulding, Tardeo, Mumbai- 400 034". |
| Jul 31, 2009 | Quarterly Results | - |
| Jun 30, 2009 | Audited Results | - |
| Jun 19, 2009 | Shifting of Registered Office & Others | To shift the registered office of the Co. from the State of West Bengal to the State of Maharashtra & to shift the corporate office of the Co. to 25, Mangaldas Road, Mumbai 400 002. |
| Feb 09, 2009 | To appoint Additional Director | inter alia, to approve the appointment of Mr. Umesh Chamdia as an Additional Director on the Board of the Company w.e.f. February 09, 2009. |
| Jan 31, 2009 | Quarterly Results | - |
| Oct 30, 2008 | Quarterly Results | - |
| Jul 30, 2008 | Quarterly Results | - |
| Jun 30, 2008 | Audited Results | - |
| Jan 31, 2008 | Quarterly Results | - |
| Oct 31, 2007 | Quarterly Results | - |
| Jun 30, 2007 | Audited Results | - |
| Oct 31, 2006 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
05 Jun 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Pursuant to Regulation 23(9) of SEBI (LODR) Regulations, 2015 please find enclosed herewith details of related party transactions for the half year ended 31st March, 2024. You are requested to kindly take the same on record and oblige. Thanking You.
29 May 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 29th May, 2024) which commenced at 04:00 P.M. and concluded at 05:30 P.M. have inter alia approved the following: ? The Board considered and approved the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March, 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the same on record and oblige. Thanking You.
22 May 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve - Consider, approve and take on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March, 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. - Consider and discuss any other routine matter or business of the company.
03 May 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 03rd May, 2024) which commenced at 01:00 P.M. and concluded at 01:30 P.M. have inter alia approved the following: 1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as internal auditors of the company for the financial year 2023-2024. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
03 May 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Please find the attached outcome of Board Meeting held today i.e. 03rd May, 2024 which commenced at 01:00 P.M. and concluded at 01:30 P.M. Kindly take the same on record and oblige. Thanking You.
29 Apr 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Submission Of Compliance Certificate Certifying The Maintenance Of Physical And Electronic Share Transfer Facility As Per Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 During The Financial Year Ended 31St March, 2024.
Dear Sir/Madam, Please find the attached certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015. You are requested to kindly take the same on record and oblige. Thanking You.
29 Apr 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2024.
Dear Sir/Madam, Please find the attached certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2024 for the financial year ended 31st March, 2024. You are requested to take the same on record and oblige. Thanking You.
29 Apr 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework.
Dear Sir/Madam, Please find the attached confirmation certificate regarding non-applicability of large corporate entity framework. You are requested to take the same on record and acknowledge the receipt. Thanking You.
29 Apr 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Undertaking Of Functional Website.
Dear Sir/Madam, With reference to the captioned subject, please find the attached undertaking of functional website. You are requested to kindly take the same on record and oblige. Thanking You.
20 Apr 2024
PRISM MEDICO AND PHARMACY LTD. - 512217 - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, With reference to the captioned subject please find the attached report on investor complaints for the quarter ended 31st March, 2024. You are requested to kindly take the same on record and oblige. Thanking You.
